Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...

Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.

Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York proposal would make things worse.

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

Michigan hospitals are systematically exploiting a program for low-income patients, according to a new report.

Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that meaningful reform requires shifting to a direct subsidy model based on need. The ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.

Lower prices on medicines. Who wouldn’t want that? In the Oklahoma Legislature, House Bill 2048 aims to expand a federal law known as 340B, which is meant to help people afford their prescriptions.